Filtered By:
Source: International Journal of Stroke
Condition: Hemorrhagic Stroke
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 132 results found since Jan 2013.
7Tesla vessel wall imaging of the basilar artery in perimesencephalic hemorrhage
Source: International Journal of Stroke - March 16, 2015 Category: Neurology Authors: Mervyn D. I. Vergouwen, Jeroen Hendrikse, Anja G. Kolk, Marieke J. H. Wermer, Maarten J. Versluis, Geert Jan Biessels, Gabriel J. E. Rinkel, Birgitta K. Velthuis Tags: Letter to the editor Source Type: research
Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema
Cerebral postischemic reperfusion injury is defined as deterioration of ischemic brain tissue that parallels and antagonizes the benefits of restoring cerebral circulation after therapeutic thrombolysis for acute ischemic stroke. To understand the paradox of injury caused by treatment, we first emphasize the phenomenon in which recanalization of an occluded artery does not lead to tissue reperfusion. Additionally, no‐reflow after recanalization may be due to injury of the neurovascular unit, distal microthrombosis, or both, and certainly worsens outcome. We examine the mechanism of molecular and subcellular damage in the...
Source: International Journal of Stroke - January 19, 2015 Category: Neurology Authors: Jilin Bai, Patrick D. Lyden Tags: Review Source Type: research
Quadriparesis due to simultaneous occurrence of hemorrhagic and ischemic stroke
Source: International Journal of Stroke - January 19, 2015 Category: Neurology Authors: E. E. Philip‐Ephraim, A. Charidimou, G. A. Kajogbola Tags: Letter to the editor Source Type: research
Stroke incidence and case‐fatality among Indigenous and non‐Indigenous populations in the Northern Territory of Australia, 1999–2011
ConclusionsIn the Northern Territory, as elsewhere in Australia, Indigenous Australians are more likely than other Australians to suffer a stroke. Lack of falling in incidence in the Northern Territory population highlights the importance for ongoing comprehensive primary and acute care in reducing risk factors and managing stroke patients.
Source: International Journal of Stroke - January 15, 2015 Category: Neurology Authors: Jiqiong You, John R. Condon, Yuejen Zhao, Steven L. Guthridge Tags: Research Source Type: research
Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI‐NVAF Study
ConclusionsWarfarin use at acute hospital discharge was still common in the initial years after approval of nonvitamin K antagonist oral anticoagulants, although nonvitamin K antagonist oral anticoagulant users increased gradually. The index stroke was milder and ischemia‐risk indices were lower in nonvitamin K antagonist oral anticoagulant users than in warfarin users. Early initiation of nonvitamin K antagonist oral anticoagulants seemed safe.
Source: International Journal of Stroke - January 12, 2015 Category: Neurology Authors: Kazunori Toyoda, Shoji Arihiro, Kenichi Todo, Hiroshi Yamagami, Kazumi Kimura, Eisuke Furui, Tadashi Terasaki, Yoshiaki Shiokawa, Kenji Kamiyama, Shunya Takizawa, Satoshi Okuda, Yasushi Okada, Tomoaki Kameda, Yoshinari Nagakane, Yasuhiro Hasegawa, Hiroshi Tags: Research Source Type: research
Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study
ConclusionsThe presence of intraventricular hemorrhage was independently associated with increased mortality, and all the intraventricular hemorrhage scores were strong predictors of three‐month mortality.
Source: International Journal of Stroke - January 1, 2015 Category: Neurology Authors: Satu Mustanoja, Jarno Satopää, Atte Meretoja, Jukka Putaala, Daniel Strbian, Sami Curtze, Elena Haapaniemi, Tiina Sairanen, Mika Niemelä, Markku Kaste, Turgut Tatlisumak Tags: Research Source Type: research
Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta‐analysis of cohort studies and randomized controlled trials
ConclusionsIn acute ischemic stroke patients receiving intravenous recombinant tissue plasminogen activator therapy, prior antiplatelet agent use did not lead to a significant difference in functional outcome, although it significantly increased the risk of symptomatic intracranial hemorrhage. Recanalization rate was not different between two groups. In the subgroup analysis, prior clopidogrel mono therapy may not increase the risk of symptomatic intracranial hemorrhage, which will need further studies to confirm.
Source: International Journal of Stroke - December 25, 2014 Category: Neurology Authors: Xiding Pan, Yubing Zhu, Danni Zheng, Yukai Liu, Feng Yu, Jie Yang Tags: Review Source Type: research
Outcomes after stroke thrombolysis according to prior antiplatelet use
ConclusionsThese results suggest no significant detrimental effect of prior antiplatelet use in AIS patients treated by IV, IA or combined IV/IA therapy. Further studies are needed to assess the specific impact of different and cumulative antiplatelet agents.
Source: International Journal of Stroke - December 1, 2014 Category: Neurology Authors: E. Meseguer, J. Labreuche, C. Guidoux, P. C. Lavallée, L. Cabrejo, G. Sirimarco, J. G. Valcarcel, I. F. Klein, P. Amarenco, M. Mazighi Tags: Systematic review Source Type: research
The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double‐blind, placebo‐controlled multicenter trial
ConclusionThe SPAD trial is the first study to evaluate the safety and efficacy of dual antiplatelet agents, aspirin plus cilostazol, in comparison with aspirin alone in patients with both ischemic stroke or TIA and PAD. Results from this trial will provide important information on the merit of adding cilostazol to aspirin for slowing down progression of atherosclerosis in patients with ischemic stroke and PAD.
Source: International Journal of Stroke - November 14, 2014 Category: Neurology Authors: Jiann‐Shing Jeng, Yu Sun, Jiunn‐Tay Lee, Ruey‐Tay Lin, Chih‐Hung Chen, Helen L. Po, Huey‐Juan Lin, Chung‐Hsiang Liu, Ming‐Hui Sun, Mu‐Chien Sun, Chang‐Ming Chern, Li‐Ming Lien, Hou‐Chang Chiu, Han‐Hwa Hu, Hung‐Yi Chiou, Sien‐Ts Tags: Protocols Source Type: research
Differences in wake‐up and unknown onset stroke examined in a stroke registry
ConclusionWUS has lower rates of ICH but similar stroke severity and outcomes to AOS. UOS prevalence appears to be increasing, with higher stroke severity and worse prognosis.
Source: International Journal of Stroke - October 1, 2014 Category: Neurology Authors: John M. Reid, Dingwei Dai, Bharath Cheripelli, Christine Christian, Yvette Reidy, Gord J. Gubitz, Stephen J. Phillips Tags: Research Source Type: research
Ambient temperature and volume of perihematomal edema in acute intracerebral haemorrhage: the INTERACT1 study
ConclusionAn apparent positive association exists between ambient temperature and perihematomal edema volume in acute spontaneous ICH.
Source: International Journal of Stroke - October 1, 2014 Category: Neurology Authors: Danni Zheng, Hisatomi Arima, Emma Heeley, Anne Karpin, Jie Yang, John Chalmers, Craig S. Anderson, Tags: Research Source Type: research
THrombolysis for Acute Wake‐up and unclear‐onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
DiscussionThis trial may help determine if low‐dose alteplase at 0·6 mg/kg should be recommended as a routine clinical strategy for ischemic stroke patients with unclear‐onset time.
Source: International Journal of Stroke - August 4, 2014 Category: Neurology Authors: Masatoshi Koga, Kazunori Toyoda, Kazumi Kimura, Haruko Yamamoto, Makoto Sasaki, Toshimitsu Hamasaki, Takanari Kitazono, Junya Aoki, Kenta Seki, Kazunari Homma, Shoichiro Sato, Kazuo Minematsu, Tags: Protocols Source Type: research
Association of baseline dyslipidemia with stroke recurrence within five‐years after ischemic stroke
ConclusionsOur results showed that DL is related to the recurrent strokes in patients with ischemic stroke within five‐years after ischemic stroke, specifically to the large‐artery disease subtype.
Source: International Journal of Stroke - August 4, 2014 Category: Neurology Authors: Emre Kumral, Dilek Evyapan, Figen Gökçay, Bedriye Karaman, Mehmet Orman Tags: Research Source Type: research
Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial
ConclusionsOur results point to a signal of efficacy and provide information to guide the subsequent phase III randomized trial of sonothrombolysis in patients with severe ischemic strokes.
Source: International Journal of Stroke - August 1, 2014 Category: Neurology Authors: Kristian Barlinn, Georgios Tsivgoulis, Andrew D. Barreto, John Alleman, Carlos A. Molina, Robert Mikulik, Maher Saqqur, Andrew M. Demchuk, Peter D. Schellinger, George Howard, Andrei V. Alexandrov Tags: Research Source Type: research
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage
ConclusionThese guidelines inform the management of ICH based on evidence for the effects of treatments in RCTs. Outcome after ICH remains poor, prioritizing further RCTs of interventions to improve outcome.
Source: International Journal of Stroke - August 1, 2014 Category: Neurology Authors: Thorsten Steiner, Rustam Al‐Shahi Salman, Ronnie Beer, Hanne Christensen, Charlotte Cordonnier, Laszlo Csiba, Michael Forsting, Sagi Harnof, Catharina J. M. Klijn, Derk Krieger, A. David Mendelow, Carlos Molina, Joan Montaner, Karsten Overgaard, Jesper Tags: Guidelines Source Type: research
